Literature DB >> 31806659

The PAX-SIX-EYA-DACH network modulates GATA-FOG function in fly hematopoiesis and human erythropoiesis.

T Michael Creed1, Rajkumar Baldeosingh2,3,4, Christian L Eberly1, Caroline S Schlee1, MinJung Kim1,5, Jevon A Cutler6, Akhilesh Pandey6, Curt I Civin1,7,8,5, Nancy G Fossett9,2,3, Tami J Kingsbury9,7,8.   

Abstract

The GATA and PAX-SIX-EYA-DACH transcriptional networks (PSEDNs) are essential for proper development across taxa. Here, we demonstrate novel PSEDN roles in vivo in Drosophila hematopoiesis and in human erythropoiesis in vitro Using Drosophila genetics, we show that PSEDN members function with GATA to block lamellocyte differentiation and maintain the prohemocyte pool. Overexpression of human SIX1 stimulated erythroid differentiation of human erythroleukemia TF1 cells and primary hematopoietic stem-progenitor cells. Conversely, SIX1 knockout impaired erythropoiesis in both cell types. SIX1 stimulation of erythropoiesis required GATA1, as SIX1 overexpression failed to drive erythroid phenotypes and gene expression patterns in GATA1 knockout cells. SIX1 can associate with GATA1 and stimulate GATA1-mediated gene transcription, suggesting that SIX1-GATA1 physical interactions contribute to the observed functional interactions. In addition, both fly and human SIX proteins regulated GATA protein levels. Collectively, our findings demonstrate that SIX proteins enhance GATA function at multiple levels, and reveal evolutionarily conserved cooperation between the GATA and PSEDN networks that may regulate developmental processes beyond hematopoiesis.
© 2020. Published by The Company of Biologists Ltd.

Entities:  

Keywords:  GATA; Hematopoiesis; PAX-SIX-EYA-DACH network; Retinal determination gene network; SIX1; SIX2

Mesh:

Substances:

Year:  2020        PMID: 31806659      PMCID: PMC6983716          DOI: 10.1242/dev.177022

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  129 in total

1.  The two origins of hemocytes in Drosophila.

Authors:  Anne Holz; Barbara Bossinger; Thomas Strasser; Wilfried Janning; Robert Klapper
Journal:  Development       Date:  2003-08-20       Impact factor: 6.868

2.  Familial dyserythropoietic anaemia and thrombocytopenia due to an inherited mutation in GATA1.

Authors:  K E Nichols; J D Crispino; M Poncz; J G White; S H Orkin; J M Maris; M J Weiss
Journal:  Nat Genet       Date:  2000-03       Impact factor: 38.330

Review 3.  The Eyes Absent proteins in development and disease.

Authors:  Emmanuel Tadjuidje; Rashmi S Hegde
Journal:  Cell Mol Life Sci       Date:  2012-09-13       Impact factor: 9.261

4.  Consequences of GATA-1 deficiency in megakaryocytes and platelets.

Authors:  P Vyas; K Ault; C W Jackson; S H Orkin; R A Shivdasani
Journal:  Blood       Date:  1999-05-01       Impact factor: 22.113

Review 5.  Ontogeny of the Drosophila larval hematopoietic organ, hemocyte homeostasis and the dedicated cellular immune response to parasitism.

Authors:  Joanna Krzemien; Michele Crozatier; Alain Vincent
Journal:  Int J Dev Biol       Date:  2010       Impact factor: 2.203

6.  Targeted disruption of the GATA3 gene causes severe abnormalities in the nervous system and in fetal liver haematopoiesis.

Authors:  P P Pandolfi; M E Roth; A Karis; M W Leonard; E Dzierzak; F G Grosveld; J D Engel; M H Lindenbaum
Journal:  Nat Genet       Date:  1995-09       Impact factor: 38.330

7.  Controlling hematopoiesis through sumoylation-dependent regulation of a GATA factor.

Authors:  Hsiang-Ying Lee; Kirby D Johnson; Tohru Fujiwara; Meghan E Boyer; Shin-Il Kim; Emery H Bresnick
Journal:  Mol Cell       Date:  2009-12-25       Impact factor: 17.970

8.  Hedgehog signaling from the Posterior Signaling Center maintains U-shaped expression and a prohemocyte population in Drosophila.

Authors:  Rajkumar Baldeosingh; Hongjuan Gao; Xiaorong Wu; Nancy Fossett
Journal:  Dev Biol       Date:  2018-07-11       Impact factor: 3.582

9.  Installation of a cancer promoting WNT/SIX1 signaling axis by the oncofusion protein MLL-AF9.

Authors:  Li-Shu Zhang; Xunlei Kang; Jianming Lu; Yuannyu Zhang; Xiaofeng Wu; Guojin Wu; Junke Zheng; Rubina Tuladhar; Heping Shi; Qiaoling Wang; Lorraine Morlock; Huiyu Yao; Lily Jun-Shen Huang; Pascal Maire; James Kim; Noelle Williams; Jian Xu; Chuo Chen; Cheng Cheng Zhang; Lawrence Lum
Journal:  EBioMedicine       Date:  2018-12-06       Impact factor: 8.143

10.  GATA-1 as a regulator of mast cell differentiation revealed by the phenotype of the GATA-1low mouse mutant.

Authors:  Anna Rita Migliaccio; Rosa Alba Rana; Massimo Sanchez; Rodolfo Lorenzini; Lucia Centurione; Lucia Bianchi; Alessandro Maria Vannucchi; Giovanni Migliaccio; Stuart H Orkin
Journal:  J Exp Med       Date:  2003-02-03       Impact factor: 14.307

View more
  4 in total

1.  Antileukemic efficacy of a potent artemisinin combined with sorafenib and venetoclax.

Authors:  Blake S Moses; Samantha McCullough; Jennifer M Fox; Bryan T Mott; Søren M Bentzen; MinJung Kim; Jeffrey W Tyner; Rena G Lapidus; Ashkan Emadi; Michelle A Rudek; Tami J Kingsbury; Curt I Civin
Journal:  Blood Adv       Date:  2021-02-09

2.  RDGN-based predictive model for the prognosis of breast cancer.

Authors:  Bing Dong; Ming Yi; Suxia Luo; Anping Li; Kongming Wu
Journal:  Exp Hematol Oncol       Date:  2020-06-15

3.  SIRT3, a metabolic target linked to ataxia-telangiectasia mutated (ATM) gene deficiency in diffuse large B-cell lymphoma.

Authors:  Kavita Bhalla; Sausan Jaber; Kayla Reagan; Arielle Hamburg; Karen F Underwood; Aditya Jhajharia; Maninder Singh; Binny Bhandary; Shambhu Bhat; Nahid M Nanaji; Ruching Hisa; Carrie McCracken; Heather Huot Creasy; Rena G Lapidus; Tami Kingsbury; Dirk Mayer; Brian Polster; Ronald B Gartenhaus
Journal:  Sci Rep       Date:  2020-12-03       Impact factor: 4.379

4.  NKL Homeobox Genes NKX2-3 and NKX2-4 Deregulate Megakaryocytic-Erythroid Cell Differentiation in AML.

Authors:  Stefan Nagel; Claudia Pommerenke; Corinna Meyer; Roderick A F MacLeod
Journal:  Int J Mol Sci       Date:  2021-10-22       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.